在肝细胞癌中超动脉化血栓化之前的甲和N-乙半氨酸:西方观点
Marco Biolato1,2, Maurizio Pompili1,3
1Department of Medical and Surgical Sciences, CEMAD Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168, Italy.
World journal of gastroenterology
|August 28, 2024
概括
预防性德克萨米他和N-乙半氨酸显著降低了肝细胞癌患者的栓塞后综合征 (PES) 和肝脏衰减. 这种组合疗法为管理跨动脉化学栓塞并发症提供了一个有希望的策略.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 干预性瘤学干预性瘤学
- 临床药理学 临床药理学
背景情况:
- 后栓塞综合征 (PES) 是肝细胞癌 (HCC) 的跨动脉化学栓塞 (TACE) 后的一个常见并发症.
- 目前用于预防PES的策略缺乏标准化的指导方针.
- 一个单中心,安慰剂对照试验研究了预防性德克萨米他和N-乙半氨酸在减少PES发病率和严重性的有效性.
更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.3K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
398
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154